ICE

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2026.

The common stock number referred in Table 1 is an aggregate number and represents 18,594 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2026.

The common stock number referred in Table 1 is an aggregate number and represents 19,927 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

The price range for the aggregate amount sold by the direct holder is $151.95 - $152.00. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

The common stock number referred in Table I is an aggregate number and represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

These options are fully vested.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

The price range for the aggregate amount sold by the direct holder is $150.46 - $151.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 17, 2026.

The common stock number referred in Table 1 is an aggregate number and represents 13,539 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2025.

The common stock number referred in Table I is an aggregate number and represents 12,914 shares of common stock and 10,117 unvested restricted stock units ("RSUs"), and 2,158 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

The common stock number referred in Table 1 is an aggregate number and represents 20,018 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

The common stock number referred in Table 1 is an aggregate number and represents 14,299 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

The common stock number referred in Table 1 is an aggregate number and represents 10,470 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Amount of securities beneficially owned includes 3 shares acquired in dividend reinvestment transactions.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

The common stock number referred in Table 1 is an aggregate number and represents 14,206 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,698 restricted stock units awarded, 1,538 were awarded as compensation for service on the Issuer's board and 160 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

The common stock number referred in Table 1 is an aggregate number and represents 3,530 shares of common stock and 1,698 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Amount of securities beneficially owned includes 11 shares acquired in dividend reinvestment transactions.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,698 restricted stock units awarded, 1,538 were awarded as compensation for service on the Issuer's board and 160 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

The common stock number referred in Table 1 is an aggregate number and represents 10,356 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

The common stock number referred in Table 1 is an aggregate number and represents 11,149 shares of common stock and 1,698 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

The common stock number referred in Table 1 is an aggregate number and represents 29 shares of common stock and 3,079 unvested restricted stock units. The restricted stock units vest on the one-year anniversary of the date of grant. Of the 3,079 unvested restricted stock units, 1,381 will vest on September 22, 2026 and 1,698 will vest on May 18, 2026.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

The common stock number referred in Table 1 is an aggregate number and represents 21,429 shares of common stock and 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 1,698 restricted stock units awarded, 1,538 were awarded as compensation for service on the Issuer's board and 160 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Europe Limited.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

The common stock number referred in Table 1 represents 1,538 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.

Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.

The price range for the aggregate amount sold by the direct holder is $155.62 - $155.96. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

The common stock number referred in Table I is an aggregate number and represents 53,660 shares of common stock, 8,907 unvested restricted stock units ("RSUs"), and 2,302 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return ("TSR") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.

The price range for the aggregate amount sold by the direct holder is $154.60 - $155.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-l trading plan which was approved and became effective as of February 12, 2026.

These options are fully vested.

These options are fully vested.

These options are fully vested.

The common stock number referred in Table I is an aggregate number and represents 142,164 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

These options are fully vested.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 7, 2025.

The common stock number referred in Table I is an aggregate number and represents 21,831 shares of common stock and 3,472 unvested restricted stock units ("RSUs"), and 959 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 year-three earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.

The common stock number referred in Table I is an aggregate number and represents 139,440 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

The price range for the aggregate amount sold by the direct holder is $161.37 - $162.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

These options are fully vested.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

The price range for the aggregate amount sold by the direct holder is $162.42 - $162.87. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction involved a gift of 200 shares of the issuer's common stock by the reporting person to a philanthropic organization.

The common stock number referred in Table I is an aggregate number and represents 40,807 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025.

The price range for the aggregate amount sold by the direct holder is $153.52 - $154.51. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025.

The price range for the aggregate amount sold by the direct holder is $152.48 - $153.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 29, 2025.

The price range for the aggregate amount sold by the direct holder is $154.52 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

The common stock number referred in Table I is an aggregate number and represents 41,398 shares of common stock and 9,805 unvested restricted stock units ("RSUs"), and 3,116 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025.

The price range for the aggregate amount sold by the direct holder is $153.58 - $154.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025.

The price range for the aggregate amount sold by the direct holder is $152.58 - $153.56. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.

The price range for the aggregate amount sold by the direct holder is $154.60 - $155.59. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

The common stock number referred in Table I is an aggregate number and represents 143,305 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 4,795 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025.

The price range for the aggregate amount sold by the direct holder is $155.62 - $155.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

The common stock number referred in Table I is an aggregate number and represents 2,662 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.

The price range for the aggregate amount sold by the direct holder is $152.56 - $153.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025.

The price range for the aggregate amount sold by the direct holder is $154.58 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.

The price range for the aggregate amount sold by the direct holder is $153.56 - $154.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2025.

The common stock number referred in Table I is an aggregate number and represents 15,404 shares of common stock and 10,117 unvested restricted stock units ("RSUs"), and 2,158 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.